CIK 0001896212 · <br>Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 873272543
- Phone
- (646) 491 9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 10-Q/A Report 10-Q/A
- 8-K Event Restatement
- 424B3 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- S-3 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Director nominations
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
Page 6 of 19 · 371 filings